Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gankang Granule is a traditional Chinese medicine formulation studied for its potential use in the treatment of advanced liver cancer, particularly in combination with first-line targeted drugs. It is being evaluated for its efficacy and mechanisms related to liver disease, including possible anti-fibrotic and anti-tumor effects. The precise herbal composition and mechanism of action are not fully detailed in available sources, but it is positioned as an adjunct therapy within integrative oncology approaches in China[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gankang Granule.